CAR-T cell therapy for cancer: current challenges and future directions by Inés Zugasti, Lady Espinosa-Aroca, Klaudyna Fidyt, Vladimir Mulens-Arias, Marina Diaz-Beya, Manel Juan, Álvaro Urbano-Ispizua, Jordi Esteve, Talia Velasco-Hernandez, Pablo Menéndez

Get full text

Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance. by Carolina Garcia-Vidal, Celia Cardozo-Espinola, Pedro Puerta-Alcalde, Francesc Marco, Adrian Tellez, Daiana Agüero, Francisco Romero-Santana, Marina Díaz-Beyá, Eva Giné, Laura Morata, Olga Rodríguez-Núñez, Jose Antonio Martinez, Josep Mensa, Jordi Esteve, Alex Soriano

Get full text

Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group by Guadalupe Oñate, Ana Garrido, Montserrat Arnan, Helena Pomares, Ester Alonso, Mar Tormo, Marina Diaz-Beya, Susana Vives, Lurdes Zamora, Antonia Sampol, Rosa Coll, Olga Salamero, Marta Cervera, Antoni Garcia, Ferran Vall-Llovera, Sara Garcia-Avila, Joan Bargay, Xavier Ortin, Eva Iranzo, Francisca Guijarro, Marta Pratcorona, Josep F. Nomdedeu, Jordi Esteve, Jorge Sierra

Get full text

Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia by Carlos Jiménez-Vicente, Iago Arribas, Helena Pomares, Guillermo Ramil, Sandra Castaño-Diez, Amanda Isabel Pérez-Valencia, Antonella Luciana Sturla, Mònica López-Guerra, Alexandra Martinez-Roca, Inés Zugasti, Francesca Guijarro, Albert Cortés-Bullich, Beatriz Merchán, Ana Triguero, Inés Monge, Albert Tuca, Guadalupe Oñate, Ana Garrido, Jorge Sierra, Montserrat Arnan, Jordi Esteve, Marina Díaz-Beyá, Spanish CETLAM Group

Get full text

Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the... by Carlos Jimenez-Vicente, Aina Cardus, Sandra Castaño-Diez, Guillermo Ramil, Sara Garcia-Avila, Lucia Gomez-Perez, Daniel Esteban, Iago Arribas, Antonella Lucia Sturla, Monica Lopez-Guerra, Alexandra Martinez-Roca, Albert Cortes-Bullich, Amanda Isabel Perez-Valencia, Ines Zugasti, Ines Monge, Esther Carcelero, Ferran Vall-Llovera, Susana Vives, Jorge Sierra, Josep Nomdedeu, Guadalupe Oñate, Ana Garrido, Marta Pratcorona, Helena Pomares, Montserrat Arnan, Francesca Guijarro, Marina Diaz-Beya, Jordi Esteve, on behalf of the Spanish CETLAM Group

Get full text

Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study by Ines Zugasti, Monica Lopez-Guerra, Sandra Castaño-Díez, Daniel Esteban, Alejandro Avendaño, Helena Pomares, Ana Perez, Sara García-Ávila, Irene Padilla Conejo, Cristina de la Fuente Montes, Alexandra Martínez-Roca, Beatriz Merchán, Carlos Jiménez-Vicente, Francesca Guijarro, Jose Ramón Álamo, Albert Cortes-Bullich, Victor Torrecillas, Lucia Mont, Esther Carcelero, Gisela Riu, Lurdes Zamora, Joan Bargay, Ana Triguero, Maria Suarez-Lledó, Maria Queralt Salas, Felix López-Cadenas, Fernando Ramos, Blanca Xicoy, David Valcárcel, Montserrat Arnan, Carmen Martínez, Montserrat Rovira, Francesc Fernández-Avilés, Maria Díez-Campelo, Jordi Esteve, Marina Díaz-Beyá

Get full text

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia by Néstor Tirado, Klaudyna Fidyt, María José Mansilla, Alba Garcia-Perez, Alba Martínez-Moreno, Meritxell Vinyoles, Juan Alcain, Marina García-Peydró, Heleia Roca-Ho, Narcis Fernandez-Fuentes, Mercedes Guerrero-Murillo, Aïda Falgàs, Talia Velasco-Hernandez, Clara Bueno, Patrizio Panelli, Vladimir Mulens-Arias, Apostol Apostolov, Pablo Engel, Europa Azucena González, Binje Vick, Irmela Jeremias, Aurélie Caye-Eude, André Baruchel, Hélène Cavé, Eulàlia Genescà, Jordi Ribera, Marina Díaz-Beyá, María Victoria Martínez-Sánchez, José Luis Fuster, Adela Escudero López, Jordi Minguillón, Antonio Pérez-Martínez, Manuel Ramírez-Orellana, Montserrat Torrebadell, Víctor M Díaz, María L Toribio, Diego Sánchez-Martínez, Pablo Menéndez

Get full text